With an additional 5M in cash burn last Q it's hard to reconcile how expenses went down Q4 over Q3. Perhaps they are ammoritizing upfront loan expense over the ten year term of the loan?
Anyway at -.28/sh they beat consensus to the upside by slightly more than Saltland and I thought they'd miss on the downside. Getting tougher and tougher to make projections here.
But they still haven't been close to consensus estimate EPS up or down in the past 5 quarters. That's simply poor guidance. Need to fix it.
Ann: AVITA Medical Reports Q4 and Full-Year 2023 Results, page-2
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.12 |
Change
-0.050(1.58%) |
Mkt cap ! $219.7M | |||
| Open | High | Low | Value | Volume |
| $3.15 | $3.15 | $3.09 | $174.0K | 55.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 221 | $3.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.13 | 399 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |